
Paolo Bonini
@paolobonini6
🔬Founder @oloBion | Scientist Entrepreneur | Metabolomics & Lipidomics Expert | Empowering Pharma, Biotech, Cosmetics & AgTech | 🌍Let's Innovate Together
ID: 1143093388335599617
https://www.researchgate.net/profile/Paolo-Bonini-2 24-06-2019 09:47:56
882 Tweet
1,1K Takipçi
1,1K Takip Edilen


Happy to share this preprint from our team, great collaboration with Mikael Knip, Pieter Dorrestein, Lahesmaa Group, and Petter Brodin. Special kudos to Santosh Lamichhane . Trajectories of microbiome-derived bile acids in early life - Insights into the progression to islet






It was a pleasure to host with Rosario today a "final" EpiLipidNET meeting online. With so many amazing speakers showcasing the success and building new plans. With Laura Goracci we will continue to work on #Epilipidomics within our Interest Group. Stay tunes and sing in!

🔴En el #DíaCienciaCRIS25, la Dra. Blanca Blanca MajemCavaller nos compartió su trabajo sobre uno de los grandes retos asociados al cáncer: la caquéxia. ¿La clave? Estudiar cómo actuar sobre el metabolismo para frenar la pérdida de peso y masa muscular en pacientes💪#CRISContraelCáncer


🔔 PUBLICATION ALERT 🔔 antiSMASH 8.0: extended gene cluster detection capabilities and analyses of chemistry, enzymology & regulation 🦠🧬 Authors from MARBLES: Mitja Zdouc, Justin van der Hooft, Gilles van Wezel 💙💛 & Marnix Medema (LeidenBiology Leiden University & @WU_BioInfo Wageningen U&R)o



This paper represents a great effort by Roman Bushuiev and his brother Anton Bushuiev. The DreaMS foundation ML model for mass spectra of small molecules now opens lots of avenues for possible downstream applications. It might be a game changer for computational metabolomics.




Some people love to build. Others? They live to break—preferably between 12-20 eV. Nicola Zamboni and Michael Witting masters of EIEIO fragmentation, where every ion meets its orchestrated doom, while they are getting a lot of fun 🔨💥🔬 Attending #metsoc2025 #MassSpec #MSMS



🚀 I am thrilled to share our new publication in Nature Communications By combining cutting-edge technology and computational innovation, uMetaP opens new doors for microbiome research and precision medicine. The full paper: rdcu.be/ewRZn Universität Wien Metaproteomics Initiative Rapid Novor Inc


